ASX Health Stocks: Polynovo notches record month, Island Pharma gets much needed cash for Phase 2a trial
Polynovo achieves record revenue month Island Pharma gets grant redirected to its dengue fever study Polynovo achieves record revenue month Polynovo (ASX:PNV) said it achieved its first ever $10m+ revenue month, after recording $10.1 million in revenue ( …